| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
| 08/02/2011 | CA2479109C Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 08/02/2011 | CA2447010C Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2011 | CA2434063C Substituted quinolines for the treatment of protozoan and retrovirus co-infections |
| 07/28/2011 | WO2011090911A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| 07/28/2011 | WO2011089623A2 Process for preparing pitavastatin and pharmaceutically acceptable salts thereof |
| 07/28/2011 | CA2788363A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| 07/27/2011 | EP2348018A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 07/27/2011 | EP2346855A2 Process for making quinolone compounds |
| 07/27/2011 | EP2346830A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 07/27/2011 | EP2346829A1 Inhibitors of stat3 |
| 07/27/2011 | EP1805166B1 Quinoline derivatives |
| 07/27/2011 | EP1443928B1 Treatment of neurodegenerative diseases and cancer of the brain |
| 07/27/2011 | CN102134219A Preparation method of quinoline derivative |
| 07/27/2011 | CN101851196B 2-(1H) quinolinone derivative, medical composition, preparation method and application thereof |
| 07/27/2011 | CN101703501B Propargyl imine compounds and use thereof in preparation of MAO inhibitor |
| 07/27/2011 | CN101538254B Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and therapeutic use |
| 07/27/2011 | CN101514187B Method for producing ethoxyquinoline |
| 07/27/2011 | CN101031557B Substituted quinolones |
| 07/26/2011 | US7985860 Process and intermediates for the synthesis of 2-(quinolin-5-yl)-4,5 disubstituted-azole derivatives |
| 07/21/2011 | WO2011086469A1 Multiphoton activable quinoline derivatives, their preparation and their uses |
| 07/21/2011 | US20110178396 Nicotinamide Derivatives |
| 07/21/2011 | US20110178092 HIV-1 Protease Inhibitors |
| 07/21/2011 | US20110178083 Pde-10 inhibitors |
| 07/21/2011 | CA2786843A1 Multiphoton activable quinoline derivatives, their preparation and their uses |
| 07/20/2011 | EP2345643A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof |
| 07/20/2011 | EP2345642A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents |
| 07/20/2011 | EP2345641A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives |
| 07/20/2011 | EP2344484A1 S1p receptors modulators and their use thereof |
| 07/20/2011 | EP2344453A2 Activators of human pyruvate kinase |
| 07/20/2011 | EP2344446A1 S1p receptors modulators |
| 07/20/2011 | EP1994005B1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents |
| 07/20/2011 | EP1685112B1 Tetrahydro-quinolinylurea derivatives as vr1 antagonists |
| 07/20/2011 | CN102131798A Di-substituted phenyl compounds used as inhibitors of phosphodiesterase 10 |
| 07/20/2011 | CN102131783A Quinoline derivatives as axl kinase inhibitors |
| 07/20/2011 | CN101768114B Synthesis method of 4-substituted-3-fluorine-2-quinolone |
| 07/20/2011 | CN101747268B Method for synthesizing 4-substituted-3-bromo-2-quinolone |
| 07/20/2011 | CN101691355B Substituted 4-quinolinone compounds and preparation method thereof |
| 07/20/2011 | CN101323590B Novel synthetic method of aripiprazole and intermediate thereof |
| 07/19/2011 | US7982043 Protein tyrosine kinase enzyme inhibitors |
| 07/19/2011 | US7981907 Thio-substituted biarylmethanesulfinyl derivatives |
| 07/19/2011 | US7981905 Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-Ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same |
| 07/19/2011 | CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 07/19/2011 | CA2420279C Selective androgen receptor modulators and methods of use thereof |
| 07/19/2011 | CA2344169C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/14/2011 | US20110172429 Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 07/14/2011 | US20110172420 Sulfonamide derivatives of polycyclic dyes used for analytical applications |
| 07/14/2011 | US20110172267 TSH receptor antagonizing tetrahydroquinoline compounds |
| 07/14/2011 | US20110172256 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 07/14/2011 | US20110172220 Discodermolide analogues and methods of their use |
| 07/14/2011 | US20110172174 Antibacterial agents |
| 07/14/2011 | US20110171270 Novel solid state forms of laquinimod and its sodium salt |
| 07/14/2011 | CA2782347A1 Quinoline amide m1 receptor positive allosteric modulators |
| 07/13/2011 | EP2343280A1 Fungicide quinoline derivatives |
| 07/13/2011 | EP2343279A1 Fused-ring derivative and medical application of same |
| 07/13/2011 | EP1885684B1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta-2 adrenergic receptor |
| 07/13/2011 | EP1610790B1 Anticancer compounds |
| 07/13/2011 | CN102123708A 8-hydroxyquinoline derivatives for the treatment of hematological malignancies |
| 07/13/2011 | CN101747267B Method for synthesizing 4-substituted-3-chlorine-2-carbostyril |
| 07/13/2011 | CN101440063B Preparation of piperaquini phosphatis |
| 07/12/2011 | US7977486 Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives |
| 07/12/2011 | US7977355 N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl |
| 07/12/2011 | US7977354 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| 07/12/2011 | US7977337 Quinoline derivatives and their use as 5-HT6 ligands |
| 07/12/2011 | CA2445341C Anthranilamides, process for their preparation, their use as antiarrhythmics, and pharmaceutical preparations thereof |
| 07/12/2011 | CA2431617C 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 07/07/2011 | WO2011081174A1 Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide |
| 07/07/2011 | WO2011080756A1 Process for the preparation of 1-phenyl-3-dimethylaminopropane derivatives |
| 07/07/2011 | WO2011080562A1 Novel aza-peptides containing 2,2-disubstituted cyclobutyl and/or substituted alkoxy benzyl derivatives as antivirals |
| 07/07/2011 | WO2011080266A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives. |
| 07/07/2011 | WO2011080265A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents |
| 07/07/2011 | WO2011080264A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof |
| 07/07/2011 | WO2011017488A3 Combination of a selective ppar-gamma modulator and an incretin for the treatment of diabetes and obesity |
| 07/07/2011 | US20110166356 Method for preparing montelukast sodium salts |
| 07/07/2011 | US20110166352 Process for making sterile aripiprazole of desired mean particle size |
| 07/07/2011 | US20110166349 Gold catalyzed hydroamination of alkynes and allenes |
| 07/07/2011 | US20110166179 Antibacterial quinoline derivatives |
| 07/07/2011 | US20110166117 Novel Compounds |
| 07/07/2011 | CA2786089A1 Nitrogen-containing heterocyclic compound and agricultural fungicide |
| 07/07/2011 | CA2783230A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives |
| 07/07/2011 | CA2783216A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents |
| 07/07/2011 | CA2783213A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof |
| 07/06/2011 | EP2339918A1 Preparation of a quinolinyloxydiphenylcyclopropanedicarboxamide |
| 07/06/2011 | EP2077996B1 Purification process of montelukast and its amine salts |
| 07/06/2011 | EP1492765B1 Novel gamma secretase inhibitors |
| 07/06/2011 | EP1442094B1 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds |
| 07/06/2011 | CN1922135B Wrinkle-diminishing agent |
| 07/06/2011 | CN1777577B Antibacterial agents |
| 07/06/2011 | CN102114432A Composite solid acid catalyst |
| 07/06/2011 | CN101356157B Process for making montelukast and intermediates therefor |
| 07/05/2011 | US7973164 Quinoline derivatives |
| 07/05/2011 | US7973160 Nitrogen-containing aromatic derivatives |
| 07/05/2011 | US7973050 5-[3-((R)(-)-5,7-Dibromo-1,2,3,4-tetrahydro-naphthalen-1-ylamino)-propylamino]-4H-thieno[3,2-b]pyridine-7-one; optically active; new target antibiotic, inhibitor of bacterial methionyl tRNA synthetase; antibiotic resistance; Clostridium difficile infection; mostly in immunodeficient, elderly |
| 07/05/2011 | US7973042 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 07/05/2011 | US7973037 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 07/05/2011 | US7973027 Compound with antimalarial activity and antimalarial drug containing the same as active ingredient |
| 07/05/2011 | US7973025 Compositions and methods of treating retinal disease |
| 07/05/2011 | CA2531484C Novel bioisosteres of actinonin |
| 07/05/2011 | CA2474386C Integrin targeted imaging agents |
| 06/30/2011 | WO2011077095A1 Quinoline derivatives used as pet imaging agents |